ATE277619T1 - Verwendung von adenosin und adenosinderivaten für analgesia - Google Patents

Verwendung von adenosin und adenosinderivaten für analgesia

Info

Publication number: ATE277619T1
Authority: AT; Austria
Prior art keywords: adenosine; analgesia; derivatives; composition; cardio
Prior art date: 1990-05-10

Application number

AT97107216T

Other languages

English (en)

Inventor

Atsuo F Fukunaga

Original Assignee

Atsuo F Fukunaga

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-05-10

Filing date

1991-05-07

Publication date

2004-10-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24077105&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE277619(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1991-05-07 Application filed by Atsuo F Fukunaga filed Critical Atsuo F Fukunaga

2004-10-15 Application granted granted Critical

2004-10-15 Publication of ATE277619T1 publication Critical patent/ATE277619T1/de

Links

OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 title abstract 4
230000036592 analgesia Effects 0.000 title abstract 3
239000002126 C01EB10 - Adenosine Substances 0.000 title abstract 2
229960005305 adenosine Drugs 0.000 title abstract 2
150000003835 adenosine derivatives Chemical class 0.000 title 1
XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 abstract 1
ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 abstract 1
XTWYTFMLZFPYCI-UHFFFAOYSA-N Adenosine diphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O XTWYTFMLZFPYCI-UHFFFAOYSA-N 0.000 abstract 1
ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 abstract 1
UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 abstract 1
208000004756 Respiratory Insufficiency Diseases 0.000 abstract 1
206010038678 Respiratory depression Diseases 0.000 abstract 1
UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 abstract 1
LNQVTSROQXJCDD-UHFFFAOYSA-N adenosine monophosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)C(OP(O)(O)=O)C1O LNQVTSROQXJCDD-UHFFFAOYSA-N 0.000 abstract 1
229960003190 adenosine monophosphate Drugs 0.000 abstract 1
230000002802 cardiorespiratory effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Pain & Pain Management (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Anesthesiology (AREA)
Biomedical Technology (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

AT97107216T 1990-05-10 1991-05-07 Verwendung von adenosin und adenosinderivaten für analgesia ATE277619T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US52152990A	1990-05-10	1990-05-10

Publications (1)

Publication Number	Publication Date
ATE277619T1 true ATE277619T1 (de)	2004-10-15

Family

ID=24077105

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AT91909913T ATE162400T1 (de)	1990-05-10	1991-05-07	Verwendung von adenosine und adenosinederivate zur anästhesie
AT97107216T ATE277619T1 (de)	1990-05-10	1991-05-07	Verwendung von adenosin und adenosinderivaten für analgesia

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AT91909913T ATE162400T1 (de)	1990-05-10	1991-05-07	Verwendung von adenosine und adenosinederivate zur anästhesie

Country Status (11)

Country	Link
EP (2)	EP0527917B2 (de)
JP (1)	JP3168025B2 (de)
AT (2)	ATE162400T1 (de)
AU (1)	AU653341B2 (de)
CA (1)	CA2082527C (de)
DE (2)	DE69133419T2 (de)
DK (1)	DK0527917T3 (de)
ES (1)	ES2113884T3 (de)
GR (1)	GR3026615T3 (de)
WO (1)	WO1991016903A2 (de)
ZA (1)	ZA913482B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6110902A (en) *	1997-06-23	2000-08-29	Moehler; Hanns	Method for the inhibition of neuronal activity leading to a focal epileptic seizure by local delivery of adenosine
DE20215415U1 (de) *	2002-10-08	2004-02-26	Biotechnologie Gesellschaft Mittelhessen Mbh	Wasserlösliche Medikamentenvorstufen von Propofol
DE102010027595A1 (de) *	2010-07-23	2012-01-26	Helmut Vorbrüggen	Vermeidung von Ischämie- oder Degenerations-Schäden im Gehirn bei Anwendung von Adenosin-Derivaten

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1172391B (it) *	1983-12-23	1987-06-18	Polifarma Spa	Composti tirpeptidici contenenti acido piroglutaminico e triptofano,procedimentio di produzione ed applicazioni terapeutiche
FR2577422B1 (fr) *	1985-02-14	1988-10-28	Roussel Uclaf	Association renfermant a titre de principes actifs, un analgesique central et l'adenine ou l'adenosine ou l'un des analogues de l'adenosine

1991
- 1991-05-07 DE DE69133419T patent/DE69133419T2/de not_active Revoked
- 1991-05-07 EP EP91909913A patent/EP0527917B2/de not_active Expired - Lifetime
- 1991-05-07 EP EP97107216A patent/EP0821964B1/de not_active Revoked
- 1991-05-07 DK DK91909913T patent/DK0527917T3/da active
- 1991-05-07 ES ES91909913T patent/ES2113884T3/es not_active Expired - Lifetime
- 1991-05-07 CA CA002082527A patent/CA2082527C/en not_active Expired - Fee Related
- 1991-05-07 AU AU78794/91A patent/AU653341B2/en not_active Ceased
- 1991-05-07 DE DE69128780T patent/DE69128780T2/de not_active Expired - Lifetime
- 1991-05-07 AT AT91909913T patent/ATE162400T1/de not_active IP Right Cessation
- 1991-05-07 AT AT97107216T patent/ATE277619T1/de not_active IP Right Cessation
- 1991-05-07 WO PCT/US1991/002951 patent/WO1991016903A2/en not_active Ceased
- 1991-05-08 ZA ZA913482A patent/ZA913482B/xx unknown
- 1991-05-09 JP JP13218691A patent/JP3168025B2/ja not_active Expired - Fee Related
1998
- 1998-04-10 GR GR980400811T patent/GR3026615T3/el unknown

Also Published As

Publication number	Publication date
AU653341B2 (en)	1994-09-29
DE69128780T2 (de)	1998-08-27
ZA913482B (en)	1992-02-26
DE69128780D1 (de)	1998-02-26
DE69133419T2 (de)	2005-11-17
EP0527917A1 (de)	1993-02-24
EP0527917B2 (de)	2006-08-16
JP3168025B2 (ja)	2001-05-21
EP0821964B1 (de)	2004-09-29
EP0527917B1 (de)	1998-01-21
ES2113884T3 (es)	1998-05-16
CA2082527C (en)	1998-07-28
WO1991016903A2 (en)	1991-11-14
EP0821964A2 (de)	1998-02-04
AU7879491A (en)	1991-11-27
WO1991016903A3 (en)	1992-05-14
GR3026615T3 (en)	1998-07-31
EP0821964A3 (de)	1998-09-02
CA2082527A1 (en)	1991-11-11
DE69133419D1 (de)	2004-11-04
DK0527917T3 (da)	1998-09-14
JPH0665079A (ja)	1994-03-08
ATE162400T1 (de)	1998-02-15

Legal Events

Date	Code	Title	Description
2005-03-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
DE3581691D1 (de)	1991-03-14	Inositoltriphosphat enthaltende stabilisierte zusammensetzung und verfahren zur stabilisierung der zusammensetzung.
ES2156852T3 (es)	2001-08-01	Citoquina mamifera, il-11.
DK0414475T3 (da)	1998-02-09	Fremgangsmåder til dyrkning af HCV i B- eller T-lymfocyt-cellelinier
DE69308908D1 (de)	1997-04-24	Verfahren zur Herstellung von Cytidin-Diphosphat-Cholin
NO970106D0 (no)	1997-01-10	Oppfangingsanalyser
ES2035668T3 (es)	1993-04-16	Uso de moleculas de adherencia intercelular y sus ligandos de union en el tratamiento del asma.
ATE92523T1 (de)	1993-08-15	Verfahren zur abtrennung und reinigung von sialyl-transferasen.
DE69110854D1 (de)	1995-08-03	Antivirusderivate von (Phosphonmethoxy)Methoxy Purin/Pyrimidin.
DE3685711D1 (de)	1992-07-23	Anordnung zur simulation von rechnerfunktionen von grossrechenanlagen.
ATE107705T1 (de)	1994-07-15	Test zur feststellung der empfänglichkeit für dns-assoziierte krankheiten.
ATE4904T1 (de)	1983-10-15	Verfahren zur herstellung von 5'-deoxy-5fluoruridin und zwischenprodukte in diesem verfahren.
DE69133419D1 (de)	2004-11-04	Verwendung von Adenosin und Adenosinderivaten für Analgesia
DE68927651D1 (de)	1997-02-27	Derivate von Fluorphosphonat-Nukleotiden
DE3768288D1 (de)	1991-04-11	Artikulator zur simulation von unterkieferbewegungen.
ATE164160T1 (de)	1998-04-15	Verfahren zur herstellung von 2-acylamino-6- halogen-purin aus 2,9-diacylguanin
DE3872888D1 (de)	1992-08-27	Immunassay unter benutzung der mikropartikelneutralisierung.
ATA238587A (de)	1990-01-15	Anordnung zur einbringung von strahlenquellen
Lloyd	1987	Multicultural counseling: Lloyd's reply.
ATE55251T1 (de)	1990-08-15	Arzneimittel mit einem 6-substituierten adenosin als aktives bestandteil.
Taylor	1990	Can we talk
Senchuk	1987	ORGANIZATION OF INTERACTION OF STUDENTS FROM DIFFERENT COURSES IN THE PROCESS OF TEACHING MATHEMATICS FOR SOCIAL COMPETENCE
IT8720225A0 (it)	1987-04-23	Composizioni cosmetiche contenenti come principio attivo adenosin monofosfato ciclico e fosfatidil inositolo o inositolo
DK553587A (da)	1988-04-24	Acylerede 9,10-anthracendicarboxaldehyd-bis-(2-imidazolin-2-ylhydrazoner), fremgangsmaade til deres fremstilling samt deres anvendelse
Votiakov et al.	1990	Theoretical bases of the epidemiology of diseases caused by noninfectious factors
ATE49693T1 (de)	1990-02-15	Verfahren und mittel zur bekaempfung des rhombenspanners boarmia rhomboidaria.